Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Future Studies Needed To Determine If 'Test And Treat' Approach Could 'End HIV Pandemic Within 50 Years,' Researchers Say
In a Journal of the American Medical Association commentary piece, Anthony Fauci and Carl Dieffenbach of the National Institute of Allergy and Infectious Diseases explore results from a WHO mathematical model study that found universal, voluntary, annual HIV testing followed up with immediate treatment for those testing positive -- the "test and treat model" -- could "reduce HIV incidence" and "end the [HIV] pandemic within 50 years." Fauci said in a written statement, "Given these conclusions, test and treat potentially could represent an important public health strategy for fighting HIV/AIDS. However, the WHO model is based on numerous assumptions that need to be tested and also raises concerns about individual rights, cost effectiveness and other critical issues that require broad public debate" (NIAID release, 6/9). In their commentary, the authors highlight the various areas of research that are necessary to verify or refute the test and treat approach (Fauci/Dieffenbach, JAMA, 6/10).

Roche To Offer Developing Countries Discounted Tamiflu
The pharmaceutical company Roche on Wednesday announced a program to help ensure developing countries have access to its antiviral Tamiflu, for "the management of a novel influenza strain defined by the WHO as having significant and current pandemic potential," Reuters reports (Egenter, 7/1). The program will make Tamiflu, which has been shown to be effective against the H1N1 (swine flu) virus, available to developing countries for "half the price normally charged," Dow Jones Newswires/Wall Street Journal reports (Mengewein, 7/1).
News of the day
International Health Organizations Urge More Funding For Yellow Fever Vaccine Stockpile
The International Coordinating Group (ICG) on Yellow Fever Vaccine Provision is warning that the global emergency stockpile of yellow fever vaccine for the world"s most vulnerable populations in Africa is under threat.
Health Insurance

Pitt School Of Medicine's George K. Michalopoulos, M.D., Ph.D., Receives 2009 ASIP Rous-Whipple Award

George K. Michalopoulos, M.D., Ph.D., Maud L. Menten Professor and chair of pathology, University of Pittsburgh School of Medicine, has received the 2009 American Society for Investigative Pathology (ASIP) Rous-Whipple Award. The award is presented annually to a senior scientist with a distinguished career in research who continues to advance the understanding of disease. Dr. Michalopoulos was honored for his research regarding the pathways of growth factors that lead the liver to regenerate. As the recipient, Dr. Michalopoulos presented a lecture on liver regeneration at ASIP"s annual meeting in New Orleans in April. His lecture will form the basis of a publication in The American Journal of Pathology. "This is a once in a lifetime achievement and I am touched to receive this recognition from my peers," said Dr. Michalopoulos. A native of Athens, Greece, Dr. Michalopoulos received his medical degree from Athens University Medical School and his doctorate in oncology from the University of Wisconsin. As one of the nation"s leading academic centers for biomedical research, the University of Pittsburgh School of Medicine integrates advanced technology with basic science across a broad range of disciplines in a continuous quest to harness the power of new knowledge and improve the human condition. Driven mainly by the School of Medicine and its affiliates, Pitt has ranked among the top 10 recipients of funding from the National Institutes of Health since 1997 and now ranks fifth in the nation, according to preliminary data for fiscal year 2008. Likewise, the School of Medicine is equally committed to advancing the quality and strength of its medical and graduate education programs, for which it is recognized as an innovative leader, and to training highly skilled, compassionate clinicians and creative scientists well-equipped to engage in world-class research. The School of Medicine is the academic partner of UPMC, which has collaborated with the University to raise the standard of medical excellence in Pittsburgh and to position health care as a driving force behind the region"s economy. For more information about the School of Medicine, see http://www.medschool.pitt.edu. University of Pittsburgh


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009